Affymax Announces Teleconference and Webcast
Affymax Announces Teleconference and Webcast
PALO ALTO, Calif.--(BUSINESS WIRE)-- Affymax, Inc. (NAS: AFFY) will host a teleconference and webcast at 5:30 a.m. Pacific Time; 8:30 a.m. Eastern Time today, February 25, to discuss the voluntary recall of OMONTYS® (peginesatide) Injection. Interested parties can listen to the live teleconference by dialing (866) 393-1565 from the U.S. or +1(973) 409-9608 for international callers. Individuals may access the live audio webcast by visiting www.affymax.com and going to the Investors section. A replay of the webcast will be available on the company's website for 30 days following the live event.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company based in Palo Alto, California. Affymax's mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses. For additional information on Affymax, please visit www.affymax.com.
Affymax, Inc.
Sylvia Wheeler, 650-812-8861
Sylvia_wheeler@affymax.com
KEYWORDS: United States North America California
INDUSTRY KEYWORDS:
The article Affymax Announces Teleconference and Webcast originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
